bpc 157 safety human adverse events bpc-157 trials effects BPC-157 and the Difference Between an Evidence Gap and a Cover-Up: What the entire human evidence base actually looks like, and the questions to ask next. — BPC-157: Experimental Peptide Creates Risk
Description
Brain lesions in rats that received cuprizone diet, and then cuprizone intragastrical applications, and thereby, cuprizone toxicity manifestations

This approach preserves milk production, provides adequate nutrients for the infant, and avoids the risks associated with any medication

Custom labeling and OEM packaging services are available for qualified partners

MF, MPP and DF have no conflicts of interest to disclose
